Applied Biosystems Receives Decision in European Patent Office Opposition
FOSTER CITY, Calif.--(BUSINESS WIRE)--Dec. 10, 2004--Applied
Biosystems (NYSE:ABI), an Applera Corporation business, today
announced that the Opposition Division of the European Patent Office
(EPO) in Munich, Germany has revoked Applera's European Patent No.
872562 covering real-time PCR thermal cycler technology.
"We disagree with the EPO's ruling and will seek to have the
patent reinstated through the appeal process," said Catherine M.
Burzik, President of Applied Biosystems.
Applera's U.S. and Japanese real-time thermal cycler patents
remain in place.
About Applera Corporation and Applied Biosystems
Applera Corporation consists of two operating groups. The Applied
Biosystems Group serves the life science industry and research
community by developing and marketing instrument-based systems,
consumables, software, and services. Customers use these tools to
analyze nucleic acids (DNA and RNA), small molecules, and proteins to
make scientific discoveries, develop new pharmaceuticals, and conduct
standardized testing. Applied Biosystems is headquartered in Foster
City, CA, and reported sales of $1.7 billion during fiscal 2004. The
Celera Genomics Group (NYSE:CRA) is engaged principally in the
discovery and development of targeted therapeutics for cancer,
autoimmune and inflammatory diseases. Celera Genomics is leveraging
its proteomic, bioinformatic, and genomic capabilities to identify and
validate drug targets, and to discover and develop small molecule
therapeutics. It is also seeking to advance therapeutic antibody and
selected small molecule drug programs in collaboration with global
technology and market leaders. Celera Diagnostics, a 50/50 joint
venture between Applied Biosystems and Celera Genomics, is focused on
discovery, development, and commercialization of diagnostic products.
Information about Applera Corporation, including reports and other
information filed by the company with the Securities and Exchange
Commission, is available at http://www.applera.com, or by telephoning
800-762-6923. Information about Applied Biosystems is available at
http://www.appliedbiosystems.com/. All information in this press
release is as of the date of the release, and Applera does not
undertake any duty to update this information, including any
forward-looking statements, unless required by law.
Copyright(C) 2004. Applera Corporation. All rights reserved.
Ana Kapor, 650-638-6227 (Media)
Linda Greub, 650-554-2349 (Investors)
David Speechly, Ph.D., (+) 44.162.273.9150
(European Media and Investors)
SOURCE: Applied Biosystems